The overlooked value of viruses - Keystone Symposia
The overlooked value of viruses - Keystone Symposia
The overlooked value of viruses - Keystone Symposia
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
material from the infecting bacteriophage, make copies <strong>of</strong> it and then insert it into an enzyme<br />
complex designed to destroy genetic material. <strong>The</strong> captured genetic material then acts as a<br />
template to guide the enzyme complex onto the bacteriophage genes and destroy them. In<br />
other words, the bacteria use the bacteriophages’ own genetic material to target them with a<br />
gene-seeking missile. This is a highly sophisticated and efficient protective mechanism. But it<br />
has now emerged that some bacteriophages have hijacked the idea and developed a similar<br />
mechanism, one that is targeted against their bacterial hosts. In particular, it was found that<br />
bacteriophages which infect cholera-causing bacteria have acquired the technology to re-target<br />
the degrading enzyme complex back onto bacterial genes responsible for controlling the antiviral<br />
response. And so the race continues.<br />
<strong>The</strong> potent anti-bacterial activity <strong>of</strong> bacteriophages has naturally led scientists to consider using<br />
them as “natural” antibiotics. As early 1896, this idea arose when Ernest Hanbury Hankin<br />
observed that water from the Ganges and Yamuna rivers in India was active against the cholera<br />
bacteria. While those early attempts to use river water to cure disease were a little premature,<br />
modern science <strong>of</strong>fers tremendous hope for harnessing these <strong>viruses</strong> for good. It is important to<br />
note here that bacteriophages are not able to infect human cells since the physiologies <strong>of</strong><br />
bacterial and human cells are very different. <strong>The</strong>refore, bacteriophages would be very safe to<br />
use in a clinical setting. Indeed, bacteriophages <strong>of</strong>fer considerable hope in our own arms race<br />
against the bacterial world, especially as we begin to run out <strong>of</strong> antibiotics against some types <strong>of</strong><br />
pathogenic bacteria. In addition to clinical applications, bacteriophages have been used to<br />
control bacterial infections in a variety <strong>of</strong> food products, including meat and cheese, and they<br />
have been considered as potential antidotes to bio-terror weapons containing the bacteria that<br />
cause diseases such as anthrax.<br />
While the potential benefits <strong>of</strong> bacteriophages are many, there are some negative aspects.<br />
Biotechnology companies that rely on the mass culture <strong>of</strong> bacteria to produce products are<br />
frequently impacted by bacteriophage infections. Even the dairy fermentation industry is<br />
impacted, with bacteriophages causing significant problems in yogurt production. In an<br />
evolutionary war, it seems you can’t win them all.<br />
David L. “Woody” Woodland, Ph.D. is the Chief Scientific Officer <strong>of</strong> Silverthorne-based <strong>Keystone</strong><br />
<strong>Symposia</strong> on Molecular and Cellular Biology, a nonpr<strong>of</strong>it dedicated to accelerating life science discovery<br />
by convening internationally renowned research conferences in Summit County and worldwide. Woody<br />
can be reached at 970-262-1230 ext. 131 or woody@keystonesymposia.org.